July 5, 2009
| Bio-IT World > Bio-IT Briefs
Bio-IT Briefs


By Staff Bio-IT World
Reporting recently in the Proceedings of the National Academy of Sciences, scientists at the Weill Medical College of Cornell University say they've devised the first-ever method of combing through the body's tens of thousands of proteins to inventory sites of S-nitrosylation (S-NO). But because these S-NO bonds are so fragile, it has been notoriously difficult to spot exactly where, among the thousands of cellular proteins, NO is reacting and having its effects.  The new technique, called SNO Site IDentification (SNOSID), quickly screens the proteome — the body's thousands of gene-expressed proteins — to find S-nitrosylation sites. The method relies on state-of-the-art mass spectrometry for sequencing amino acids from hundreds of peptides in protein digests obtained from cells and organs. "It's a real breakthrough for both basic science and drug research — a tool that should significantly accelerate our understanding of nitric oxide signaling," says senior researcher Dr. Steven S. Gross, Professor of Pharmacology at Weill Cornell Medical College. Read the press release.

The journal PLoS Genetics has published the findings of a team of scientists at the Boston Biomedical Research Institute that provides a whole genome analysis of the protein kinases from a scientifically valuable model organism known as Dictyostelium. Led by Dr. Janet Smith, this study offers important insights into the evolution of kinases, which are enzymes involved in cell communication pathways. To solve the kinome of Dictyostelium, Smith and her colleagues utilized the power of bioinformatics, a scientific technique which employs databases and computer algorithms to allow researchers to gain information and compile data about genes and kinases in a fast and efficient way, which can be very useful for drug discovery and development. Read the article.

Phase Forward announced Central Coding for InForm, a new Web-based application that is optimized to work with InForm Integrated Trial Management (ITM), Phase Forward’s electronic data capture (EDC) product. Central Coding for InForm automatically standardizes clinical trial data input to provide cleaner data more quickly and efficiently for organizations conducting clinical trials. Read the press release.

 

 

 

 

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

thomson reuters image
Biomarkers: An Indispensible Addition to the Drug Development Toolkit
Examining the Potential of Biomarkers
Sponsored by Thomson Reuters

Biomarkers are becoming an essential part of clinical development. In this white paper, Thomson Reuters provides insight from experts in industry and academia, and explores the role of biomarkers as evaluative tools in improving clinical research and the challenges this presents.

Discover the potential of biomarkers to:

  • Improve decision making
  • Accelerate drug development
  • Reduce development costs


BlueArc_Scientific Data
Scientific Data Lifecycle Management: Preparing for Storage in an Uncertain Future
Sponsored by BlueArc

Managing vast and overwhelming streams of gene sequencing data today requires ultra-high performance systems and processes. With continued rapid advancement and improvements in gene sequencing, expect tomorrow’s instruments to output quantities of genomic information that will dwarf current levels. Help your organization maintain data control and prepare for the future of sequencing through this informative paper that discusses:

  • The information technology challenges of gene sequencing
  • “Intelligent” methods for data management and customization
  • System survival tips... Deciding what data to keep or delete
  • New tools to keep scientists ahead of impending data torrents


SAS Managed image
Managed Innovation, Assured Compliance
Developing, executing and managing the transformation, analysis and submission of clinical research data with SAS® Drug Development
Sponsored by SAS
Get better products to market faster. Download this white paper to discover the top ten challenges facing life science executives and how to overcome them. See how SAS Drug Development transforms clinical data into true innovation.


Life Science Webcasts & Podcasts

Presented by Trade Commission of Spain

Spain Biotech: An Engine for Economic Change 

TCS podcastDiscover how Spain is focusing on biotechnology to be an engine for economic change through gradual internationalization, development and technology transfer.

Regional governments are actively investing in public and private biology research and promoting the creation of knowledge-based companies. Spain’s human capital combined with aggressive investment in biotech research and infrastructure has led to the creation of bio-clusters.

Today, there are nearly 700 Spanish companies engaged in biotechnology, with almost 50 percent growth in funding devoted to research. In fact, spending on internal R & D in biotechnology has grown 46 percent and is close to 300 million Euros.

Access the podcast 

 



More Podcasts

Job Openings

saic_logo

MANAGER, SCIENTIFIC COMPUTING & PROGRAMMING
(Bioinformatics Manager)
SAIC-Frederick, Inc has an exciting opportunity for a Manager, Scientific Computing & Programming - Core Genoytyping Facility in Gaithersburg, Maryland.  In this role, you will lead the Bioinformatics & Analysis Group.
Master’s or equivalent required.  PhD preferred. Six years experience in development of scientific programs in high-performance computing environment including five years supporting scientific research in computational chemistry, biology, or genetics, & two years supervisory experience.  View complete job posting & apply: www.saic-frederick.com. Position #146945.





For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.